2025 Pharma Partnering Prospectus
Partnership Opportunities for Legal & Financial Services
The fifth in a portfolio of seven hyper-relevant, life science business networking forums, consider involving your marketing team to meet biotech CEOs and present a targeted, industry-specific, and scientifically aligned message, to differentiate your capabilities versus competitors. Â
Without expanding the target universe, pharma has limited druggable opportunities, patent cliffs, and an increasingly competitive and demanding drug development market. Drugging the undruggable with targeted protein degradation (TPD) is one answer to reaching new proteins of therapeutic potential.Â
Targeted Message for Networking & Business Growth
Engage with over 80 companies expanding target discovery beyond current druggable opportunities across oncology, neurology and autoimmune disease. Build connections with pharma and biotech decision-makers actively seeking solutions for optimizing patent strategies, building an appealing data room for deals, launching IPOs, and meeting the right future contacts for M&A, or investment.Â
Insights into Industry Trends & Private Biotech Updates
Stay ahead of the curve by understanding the rapidly evolving landscape of protein degradation and molecular glue therapeutics. Gain actionable insights into attractive technologies and targets for pharma, reporting from public and private biotech to compare companies, and market dynamics that influence the development of PROTACs, molecular glues, and related bifunctional degraders.Â